Economical evaluation of darunavir plus low dose ritonavir intreatment-experienced HIV-1-infected patients

被引：0
|
作者：
Vorobiev, P. [1 ]
Avksentieva, M. [1 ]
Lesnicheva, M. [2 ]
机构：
[1] Moscow Med Acad, Moscow, Russia
[2] Russian Soc Pharmacoecon & Outcomes Res, Moscow, Russia
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70317-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A98 / A98
页数：1
相关论文
共 50 条
  • [21] Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)
    Taiwo, Babafemi
    Zheng, Lu
    Gallien, Sebastien
    Matining, Roy M.
    Kuritzkes, Daniel R.
    Wilson, Cara C.
    Berzins, Baiba I.
    Acosta, Edward P.
    Bastow, Barbara
    Kim, Peter S.
    Eron, Joseph J., Jr.
    AIDS, 2011, 25 (17) : 2113 - 2122
  • [22] Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
    Luis Casado, Jose
    Banon, Sara
    Moreno, Ana
    Diaz de Santiago, Alberto
    Gomez, Cristina
    Perez-Elias, Maria J.
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 188 - 188
  • [23] Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice
    Armenia, Daniele
    Bouba, Yagai
    Gagliardini, Roberta
    Fabeni, Lavinia
    Borghi, Vanni
    Berno, Giulia
    Vergori, Alessandra
    Cicalini, Stefania
    Mussini, Cristina
    Antinori, Andrea
    Ceccherini-Silberstein, Francesca
    Perno, Carlo Federico
    Santoro, Maria Mercedes
    HIV MEDICINE, 2021, 22 (06) : 519 - 525
  • [24] Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naive patients: analysis of data in the real-world setting in Italy
    Antinori, Andrea
    Borderi, Marco
    Cauda, Roberto
    Bini, Teresa
    Chirianni, Antonio
    Squillace, Nicola
    Mancusi, Daniela
    Termini, Roberta
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 58 - 59
  • [25] Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)
    Molina, Jean-Michel
    Gallien, Sebastien
    Chaix, Marie-Laure
    El Abbassi, El Mountacer
    Madelaine, Isabelle
    Katlama, Christine
    Valin, Nadia
    Delobel, Pierre
    Desseaux, Kristell
    Peytavin, Gilles
    Saillard, Juliette
    Raffi, Francois
    Chevret, Sylvie
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (08) : 2129 - 2136
  • [26] Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults
    Arathoon, Eduardo
    Bhorat, Asad
    Silaghi, Rodica
    Crauwels, Herta
    Lavreys, Ludo
    Tambuyzer, Lotke
    Vanveggel, Simon
    Opsomer, Magda
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 177 - 178
  • [27] Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals
    Soria, A
    Gianotti, N
    Cernuschi, M
    Lazzarin, A
    MICROBIOLOGICA, 2004, 27 (01): : 11 - 15
  • [28] Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
    Antinori, Andrea
    Meraviglia, Paola
    Monforte, Antonella d'Arminio
    Castagna, Antonella
    Mussini, Cristina
    Bini, Teresa
    Gianotti, Nicola
    Rusconi, Stefano
    Colella, Elisa
    Airoldi, Giuseppe
    Mancusi, Daniela
    Termini, Roberta
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1589 - 1603
  • [29] Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
    Ortiz, Roberto
    DeJesus, Edwin
    Khanlou, Homayoon
    Voronin, Evgeniy
    van Lunzen, Jan
    Andrade-Villanueva, Jaime
    Fourie, Jan
    De Meyer, Sandra
    De Pauw, Martine
    Lefebvre, Eric
    Vangeneugden, Tony
    Spinosa-Guzman, Sabrina
    AIDS, 2008, 22 (12) : 1389 - 1397
  • [30] Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients
    Crommentuyn, KML
    Kappelhoff, BS
    Mulder, JW
    Mairuhu, ATA
    van Gorp, ECM
    Meenhorst, PL
    Huitema, ADR
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (04) : 378 - 389
12345